Cagrilintide is a synthetic analog of amylin, a naturally occurring peptide hormone co-secreted with insulin from pancreatic beta cells. This research-grade peptide is designed for in vitro and laboratory research applications only, providing researchers with a high-purity compound for metabolic and endocrine studies.
As a dual agonist targeting both amylin and calcitonin receptors, Cagrilintide offers unique research opportunities for investigating complex metabolic signaling pathways. Its enhanced stability profile and extended half-life make it particularly valuable for long-term research protocols and mechanistic studies examining hormone-receptor interactions.
Technical Specifications
- Molecular Formula: C₁₇₁H₂₆₅N₄₅O₅₃S₂
- Molecular Weight: 3,706.4 Da
- Purity: ≥99% (HPLC verified)
- Vial Contents: 10mg lyophilized powder
- Storage: Store at -18°C to -22°C
- Stability: 24 months at recommended storage conditions
- Reconstitution: Bacteriostatic water recommended for research applications
Quality Assurance Each batch of Cagrilintide peptide undergoes rigorous third-party testing through Freedom Diagnostic Testing to ensure:
- Peptide identity confirmation via mass spectrometry
- Purity verification through high-performance liquid chromatography (HPLC)
- Endotoxin levels below research standards
- Certificate of Analysis (COA) included with every order
Research Applications
Cagrilintide is utilized in research studies investigating:
- Metabolic pathway mechanisms
- Glucose homeostasis research
- Amylin receptor interactions
- Pancreatic beta cell function studies
- Endocrine system research
Recent Study Featured on NIH library of medicine
Important Research Notice: This product is intended for research use only. Not for human consumption, therapeutic use, or diagnostic purposes. Researchers should consult relevant scientific literature and institutional guidelines before use.
